Resources Management Corp CT ADV Purchases 138 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Resources Management Corp CT ADV raised its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 30.3% during the second quarter, Holdings Channel.com reports. The fund owned 593 shares of the exchange traded fund’s stock after buying an additional 138 shares during the period. Resources Management Corp CT ADV’s holdings in SPDR S&P Biotech ETF were worth $55,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the business. Avoro Capital Advisors LLC bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $396,844,000. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of SPDR S&P Biotech ETF by 30.3% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares during the last quarter. Jane Street Group LLC lifted its position in shares of SPDR S&P Biotech ETF by 68.7% in the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after buying an additional 391,333 shares in the last quarter. Bessemer Group Inc. boosted its stake in SPDR S&P Biotech ETF by 1.7% during the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock valued at $87,572,000 after buying an additional 15,794 shares during the last quarter. Finally, Mirae Asset Securities USA Inc. purchased a new position in SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $55,626,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $98.75 on Wednesday. The company has a market cap of $7.53 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The stock’s 50 day simple moving average is $98.95 and its two-hundred day simple moving average is $93.90.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.